» Articles » PMID: 35782499

Bone Engineering Scaffolds With Exosomes: A Promising Strategy for Bone Defects Repair

Overview
Date 2022 Jul 5
PMID 35782499
Authors
Affiliations
Soon will be listed here.
Abstract

The treatment of bone defects is still an intractable clinical problem, despite the fact that numerous treatments are currently available. In recent decades, bone engineering scaffolds have become a promising tool to fill in the defect sites and remedy the deficiencies of bone grafts. By virtue of bone formation, vascular growth, and inflammation modulation, the combination of bone engineering scaffolds with cell-based and cell-free therapy is widely used in bone defect repair. As a key element of cell-free therapy, exosomes with bioactive molecules overcome the deficiencies of cell-based therapy and promote bone tissue regeneration via the potential of osteogenesis, angiogenesis, and inflammation modulation. Hence, this review aimed at overviewing the bone defect microenvironment and healing mechanism, summarizing current advances in bone engineering scaffolds and exosomes in bone defects to probe for future applications.

Citing Articles

Development of Functionalized Poly(ε-caprolactone)/Hydroxyapatite Scaffolds via Electrospinning 3D for Enhanced Bone Regeneration.

Lima M, de Melo E, Alves K, de Sa F, Junior S ACS Omega. 2024; 9(45):45035-45046.

PMID: 39554400 PMC: 11561599. DOI: 10.1021/acsomega.4c05264.


Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone-Related Diseases: Intercellular Communication Messengers and Therapeutic Engineering Protagonists.

Wang Y, Wen J, Lu T, Han W, Jiao K, Li H Int J Nanomedicine. 2024; 19:3233-3257.

PMID: 38601346 PMC: 11005933. DOI: 10.2147/IJN.S441467.


Schwann Cell-Derived Exosomal Vesicles: A Promising Therapy for the Injured Spinal Cord.

Ghosh M, Pearse D Int J Mol Sci. 2023; 24(24.

PMID: 38139147 PMC: 10743801. DOI: 10.3390/ijms242417317.


Resorbable Biomaterials Used for 3D Scaffolds in Tissue Engineering: A Review.

Vach Agocsova S, Culenova M, Birova I, Omanikova L, Moncmanova B, Danisovic L Materials (Basel). 2023; 16(12).

PMID: 37374451 PMC: 10301242. DOI: 10.3390/ma16124267.


Hyaluronic acid-based hydrogels: As an exosome delivery system in bone regeneration.

Deng H, Wang J, An R Front Pharmacol. 2023; 14:1131001.

PMID: 37007032 PMC: 10063825. DOI: 10.3389/fphar.2023.1131001.


References
1.
Cao Z, Wu Y, Yu L, Zou L, Yang L, Lin S . Exosomal miR-335 derived from mature dendritic cells enhanced mesenchymal stem cell-mediated bone regeneration of bone defects in athymic rats. Mol Med. 2021; 27(1):20. PMC: 7913386. DOI: 10.1186/s10020-021-00268-5. View

2.
Schmidt A . Autologous bone graft: Is it still the gold standard?. Injury. 2021; 52 Suppl 2:S18-S22. DOI: 10.1016/j.injury.2021.01.043. View

3.
Majidinia M, Sadeghpour A, Yousefi B . The roles of signaling pathways in bone repair and regeneration. J Cell Physiol. 2017; 233(4):2937-2948. DOI: 10.1002/jcp.26042. View

4.
Luo Z, Li F, Liu Y, Rao S, Yin H, Huang J . Aptamer-functionalized exosomes from bone marrow stromal cells target bone to promote bone regeneration. Nanoscale. 2019; 11(43):20884-20892. DOI: 10.1039/c9nr02791b. View

5.
Zhou P, Xia D, Ni Z, Ou T, Wang Y, Zhang H . Calcium silicate bioactive ceramics induce osteogenesis through oncostatin M. Bioact Mater. 2020; 6(3):810-822. PMC: 7528055. DOI: 10.1016/j.bioactmat.2020.09.018. View